发明申请
- 专利标题: HETEROCYCLIC COMPOUND
-
申请号: US16230634申请日: 2018-12-21
-
公开(公告)号: US20190119225A1公开(公告)日: 2019-04-25
- 发明人: Yoshihiro Banno , Masahiro Kamaura , Kazuaki Takami , Koichiro Fukuda , Shigekazu Sasaki
- 申请人: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 申请人地址: JP Osaka
- 专利权人: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 当前专利权人: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- 当前专利权人地址: JP Osaka
- 优先权: JP2014-217770 20141024
- 主分类号: C07D263/46
- IPC分类号: C07D263/46 ; C07D213/70 ; A61P27/02 ; C07D239/34 ; A61K31/421 ; C07D213/65 ; C07D263/38 ; A61K31/415 ; C07D231/22 ; C07D231/12 ; A61K31/505 ; A61K31/4418
摘要:
Provided is a heterocyclic compound having a superior RBP4-lowering action and useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4.A compound represented by the formula (I): wherein each symbol is as defined in the Description, or a salt thereof has a superior RBP4-lowering action, and is useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4.
公开/授权文献
- US10544111B2 Heterocyclic compound 公开/授权日:2020-01-28
信息查询